Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 169M | 196M | 185M | 162M | 183M | 190M |
| Cost of revenue | 119M | 132M | 126M | 115M | 128M | 133M |
| Gross profit | 45M | 58M | 54M | 41M | 49M | 51M |
| Research and development | 221,000 | 210,000 | 269,000 | 299,000 | 241,000 | 231,000 |
| Selling, general and administrative | 37M | 33M | 40M | 36M | 33M | 36M |
| Operating income | 5M | 20M | 8M | −1M | 12M | 12M |
| Pre-tax income | 3M | 17M | 4M | −4M | 9M | 8M |
| Income tax | 378,000 | 4M | 1M | −1M | 3M | 1M |
| Net income | 2M | 13M | 3M | −3M | 6M | 6M |
| Earnings per share | 0.08 | 0.42 | 0.10 | −0.10 | 0.21 | 0.21 |
| Earnings per share, diluted | 0.07 | 0.41 | 0.10 | −0.10 | 0.20 | 0.20 |
| Weighted average shares | 32M | 32M | 31M | 31M | 31M | 31M |
| Weighted average shares, diluted | 33M | 32M | 32M | 31M | 32M | 31M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 25M | 28M | 28M | 20M | 19M | 18M | 20M | 17M |
| Receivables | 151M | 155M | 175M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 3M | — | — | 6M | — | — |
| Depreciation and amortisation | 8M | 2M | 2M | 8M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 160M |
| 128M |
| 127M |
| 144M |
| 150M |
| Inventory | 15M | 14M | 15M | 15M | 14M | 14M | 15M | 15M |
| Current assets | 211M | 216M | 237M | 213M | 176M | 172M | 193M | 193M |
| Goodwill | 184M | 185M | 184M | 185M | 182M | 181M | 186M | 185M |
| Total assets | 573M | 579M | 596M | 571M | 527M | 523M | 552M | 548M |
| Current liabilities | 117M | 124M | 126M | 128M | 118M | 115M | 115M | 115M |
| Short-term debt | 13M | 13M | 13M | 13M | 12M | 12M | 11M | 10M |
| Long-term debt | 168M | 165M | 189M | 176M | 160M | 158M | 179M | 190M |
| Total liabilities | 339M | 343M | 368M | 355M | 328M | 324M | 346M | 355M |
| Equity | 233M | 235M | 227M | 216M | 199M | 199M | 206M | 193M |
| Shares outstanding | 32M | 32M | 32M | 32M | 31M | 31M | 31M | 31M |
| Shares issued | 32M | 32M | 32M | 32M | 31M | 31M | 31M | 31M |
| 2M |
| 2M |
| Share-based compensation | 1M | — | — | 2M | — | — |
| Capital expenditure | 6M | — | — | 5M | — | — |
| Investing cash flow | −6M | — | — | −5M | — | — |
| Financing cash flow | −349,000 | — | — | −702,000 | — | — |